Table 2.
Baseline prescribed medication use among participants (N = 271) enrolled in the Brain in Motion study (listed alphabetically)
| Prescribed medications | % total participants (number) |
|---|---|
| Drugs used for diabetes | 4.4% (12) |
| Anticonvulsant | 3.0% (8) |
| Antihypertensive/ cardiovascular agents | |
| bACE Inhibitor | 8.9% (24) |
| Angiotensin Receptor blocker | 12.5 (34) |
| Beta blocker | 3.7% (10) |
| Calcium Channel blocker | 10.0% (27) |
| Diuretic | 14.0% (38) |
| Analgesic | |
| b,aNSAID | 12.2% (33) |
| Opioid Analgesic | 3.3% (9) |
| Antidepressant | 14.4% (39) |
| Benign Prostrate Hyperplasia Agent | |
| Alpha blocker | 2.6% (7) |
| Cholesterol lowering agent | |
| bHMG-CoA reductase inhibitors (Statins) | 19.2% (52) |
| Hormonal agent | |
| Estrogen | 9.2% (25) |
| Corticosteroid | 7.4% (20) |
| Progesterone | 2.6% (7) |
| Thyroxine | 17.0% (46) |
| Proton Pump Inhibitor | 7.4% (20) |
| Sleep aids | |
| Melatonin Receptor Agonist | 3.3% (9) |
| Sedatives | 12.2% (33) |
| Other | |
| Antispasmodic | 3.3% (9) |
| Bisphosphonate | 7.0% (19) |
| Prostaglandin | 5.9% (16) |
| Other | 24.7% (67) |
| None | 24.7% (67) |
b ACE Angiotensin Converting Enzyme
NSAID Non-Steroidal Anti-Inflammatory Drug
HMG-CoA 3-Hydroxy-3-Methyl-Glutaryl-CoA
aThese include only prescribed NSAIDs